New Haven Connecticut based Allyx Therapeutics is raising $8,031,491.00 in New Equity Investment.
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, Allyx Therapeutics is raising $8,031,491.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Stephen Bloch played…